Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Durolane vs methylprednisolone for knee osteoarthritis pain
2006-006485-42Phase 4Completed
- Sponsor
- Galderma
- Start
- Jan 2007
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hyaluronic acid in knee osteoarthritis (OA) (2 arms), sponsored by Galderma. Primary endpoint: WOMAC pain responder rate at 12 weeks. Started Jan 2007; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-006485-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006485-42.